Suppression of Bronchial Response to Platelet Activating Factor Following Taurine Administration

Almazov, V.A., Gurerich, V.S., Mikhailova, I.A., and Streltaova, E.N., 1985, The influence of taurine on Ca²⁺, Mg²⁺, ATPase activity and aggregation of human platelet (Russian), Byull. Ekap. Biol. Med., 100:398–400.Google Scholar

Bennett, J., Thibaudeau, D., and Bessin, P., 1983, Dependency of the PAF-acether induced bronchospasm on the lipoxygenase pathway in the guinea pig, Prostaglandins, 26:457–466.CrossRefGoogle Scholar

Chignard, M., LeCouedic, J.P., Tence, M., Vargaftig, B.B., and Benveniste, J., 1979, The role of platelet-activating factor in platelet aggregation, Nature, 279:799–800.PubMedCrossRefGoogle Scholar

Darius, H., Lefer, D.J., Smith, J.B., and Lefer, A.M., 1986, Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis, Science, 232:58–60.PubMedCrossRefGoogle Scholar

Demopoulos, C.A., Pinckard, R.N., and Hanahan, D.J., 1979, Platelet activating factor. Evidence for 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators), J. Biol. Chem., 254:9355–9358.PubMedGoogle Scholar

Fitzgerald, M.F., Moncada, S., and Parente, L., 1986, The anaphylactic release of platelet-activating factor from perfused guinea pigs, Br. J. Pharmac., 88:149–153.CrossRefGoogle Scholar

Gaut, Z.N., and Nauss, C.B., 1976, Uptake of taurine by human blood platelets: A plssible model for brain, in: “Taurine”, R. J. Huxtable and A. Barbeau eds., Raven Press, New York, pp. 91–98.Google Scholar

Hwang, S., Lam, M., Li, C, and Shen, T., 1986, Release of platelet activating factor and its involvement in the first phase of carrageenin-induced rat foot edema, Eur. J. Pharmac., 120:33–41.CrossRefGoogle Scholar

Inarrea, P., Gomez-Cambronero, J., Nieto, M., and Crespo, M.S., 1984, Characteristics of the binding of platelet-activating factor to platelets of different animal species, Eur. J. Pharmac, 105:309–315.CrossRefGoogle Scholar

Jacobsen, J.G., and Smith, L.H., 1968, Biochemistry and physiology of taurine and taurine derivatives, Physiol. Rev., 48:424–511.PubMedGoogle Scholar

Konzett, H., and Rossler, R., 1940, Verschsanordnung zu Utersuchungen an der Bronchialmuskulatur, Naunyn-Schmiedebergs Arch. Exp. Path. Pharmak., 195:71.CrossRefGoogle Scholar

Lee, T-C., Mlone, B., Blank, M.L., and Snyder, F., 1981, l-Alkyl 2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) stimulates calcium influx in rabbit platelet, Biochem. Biophys. Res. Commun., 102:1262–1268.PubMedCrossRefGoogle Scholar

Maridonneau-Parini, I., Lagente, V., Lefort, J., Russo-Marie, F., and Vargaftig, B.B., 1985, Desensitization to PAF-induced bronchoconstriction and to activation of th alveolar macrophages by repeated inhalations of PAF in the guinea pig, Biochem. Biophys. Res. Commun., 131:42–49.PubMedCrossRefGoogle Scholar

Namm, D.H., Tadepalli, A.S., and High, J.A., 1982, Species specificity of the platelet responses to l-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine, Thromb. Res., 25:341–350.PubMedCrossRefGoogle Scholar

Robertson, D.N., and Smith, G.M., 1986, Cv88 inhibits in vivo platelet aggregation induced by PAF-acether and collagen, Eur. J. Pharmac, 123:91–97.CrossRefGoogle Scholar

Shaw, J.O., Klusick, S.J., and Hanahan, D.J., 1981, Activation of rabbit platelet phospholipase and thromboxane synthesis by 1-0-hexadecy1/-octadecyl-2-acetyl-2-sn-glyceryl-3-phosphorylcholine (platelet activating factor), Biochem. Biophys. Acta, 663:222–229.PubMedCrossRefGoogle Scholar

Vargaftig, B.B., and Benveniste, J., 1983, Platelet-activating factor today, Trends Pharmacol. Sci., 4:341–344.CrossRefGoogle Scholar

Vargaftig, B.B., Chignard, M., Benveniste, J., Lefort, J., and Wal, F., 1981, Background and present status of research on platelet-activating factor (PAF-acether), Ann. N. Y. Acad. Sci., 370:119–137.PubMedCrossRefGoogle Scholar

Vargaftig, B.B., Lefort, J., Chignard, M., and Benveniste, J., 1980, Platelet-activating factor induces a platelet-dependent broncho-constriction unrelated to the formation of prostaglandin derivatives, Eur. J. Pharmac., 65:185–192.CrossRefGoogle Scholar

Young, J.M., Maloney, P.J., Jobb, S.N., and Clark, J.S., 1985, Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse, Prostaglandins, 30:545–551.PubMedCrossRefGoogle Scholar